Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy

Purpose: Multi-drug resistant tuberculosis (MDR-TB) and extremely drug resistant (XDR) TB are big problems in the world. We have developed novel TB therapeutic vaccines, HVJ-Envelope/HSP65 + IL-12 DNA vaccine (HSP65-vaccine), granulysin vaccine and killer specific secretory protein of 37kDa (Ksp37)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kita, Yoko, Hashimoto, Satomi, Nakajima, Toshihiro, Nakatani, Hitoshi, Nishimatsu, Shiho, Nishida, Yasuko, Kanamaru, Noriko, Kaneda, Yasuhumi, Takamori, Yasushi, McMurray, David, Tan, Esterlina V., Cang, Marjorie L., Saunderson, Paul, Dela Cruz, E.C., Okada, Masaji
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891708/
https://ncbi.nlm.nih.gov/pubmed/23249609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.23230
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars